REG - FTSE Russell GSK PLC - GSK

GSKAnnouncement

11/07/2022 17:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220711:nRSK0768Sa&default-theme=true

RNS Number : 0768S  FTSE Russell  11 July 2022

 

GSK (UK): Demerger of Haleon (UK)

Changes in FTSE UK Index Series

11 July 2022

 Further to the FTSE Russell notice released 15 June 2022
 (https://research.ftserussell.com/products/index-notices/home/getnotice/?id=2604687)
 and subject to the completion of the demerger of Haleon (UK, non-constituent)
 from GSK (UK, constituent), please see details of affected indexes and
 effective dates below:

 

 Index                        Effective From

Start of Trading
 FTSE 100 Index               18 July 2022
 FTSE 350 Index               18 July 2022
 FTSE All-Share Index         18 July 2022
 FTSE 350 Higher Yield Index  18 July 2022
 Techmark All Share Index     18 July 2022
 FTSE UK Dividend + Index     18 July 2022

 

 

 

 

 

 

 For further information please contact FTSE Russell Client Services at
 info@ftserussell.com or call:

Australia  +1800 653 680
 Hong Kong  +852 2164 3333
 Japan      +81 3 6441 1440
 London     +44 (0) 20 7866 1810
 New York   +1866 551 0617

 

 Alternatively please visit our website at www.ftserussell.com

 Terms of Use (http://www.ftserussell.com/legal/website-terms-use) | Copyright
 © 2022 FTSE Russell

 

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use (http://www.ftserussell.com/legal/website-terms-use) | Copyright
© 2022 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FTSQFLFFLDLBBBF